Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Enefluid
- Development stage
- Unknown
- Lead developer
- Otsuka Pharmaceutical Factory, Inc.
- Modality
- Small Molecules, Peptides
- Administration
- Intravenous, Parenteral
01
Overview
Enefluid is a peripheral parenteral nutrition (PPN) solution developed and marketed by **Otsuka Pharmaceutical Factory**. It is a combination product containing glucose, amino acids, electrolytes, and Vitamin B1 (thiamine). Enefluid is specifically designed to provide nutritional support to patients who cannot obtain sufficient nutrition orally or enterally. It is the first PPN solution in Japan to incorporate Vitamin B1, which is essential for carbohydrate metabolism and helps prevent complications such as Wernicke's encephalopathy and lactic acidosis that can occur when glucose is administered to thiamine-deficient patients. In clinical practice, it is also utilized for intradialytic parenteral nutrition (IDPN) to treat malnutrition in patients undergoing maintenance hemodialysis.
- Brand names
- Enefluid
- Other names
- ENEFLUID InjectionGlucose, Amino Acids, Electrolytes, and Vitamin B1 Injection
02
Targets
SERPINA1 (Alpha-1-antitrypsin)SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)PDH (Pyruvate dehydrogenase complex)
Beyond the preview
Go deeper on Enefluid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enefluid.